Barclays Maintains Overweight on MetLife, Raises Price Target to $94

Benzinga Newsdesk www.benzinga.com Positive 72.1%

Neg 0% Neu 0% Pos 72.1%

Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $93 to $94.

Comments

No comments yet. Be the first!